octodrine octodrine octodrine (also known as vaporpac or dmha) is a stimulant drug whose pharmacology was studied in a dozen animal studies from the 1940s through the 1970s. these studies found that octodrine can increase blood pressure and cardiac output in animals. the drug was previously approved for use by the fda as an inhalant (i.e., vaporpac and tickle tackle inhaler) and in germany as an oral agent as part of a multicomponent medication (i.e., ambredin and ordinal), but is no longer available. octodrineclinical dataother namesdmha; ottodrina; vaporpac; amidrine; 2-aminoisoheptane; 2-amino-6-methylheptane; 1,5-dimethylhexylamine; 6-methyl-2-heptylamine; 6-methyl-2-heptanamineroutes ofadministrationoral, inhaledatc codenonelegal statuslegal status not currently marketed anywhere, hydrochloride salt is sold as a designer drug online. identifiers iupac name 6-methylheptan-2-amine cas number543-82-8 npubchem cid10982chemspider10517unii3gq9e911bicomptox dashboard (epa)dtxsid8046535 echa infocard100.008.047 chemical and physical dataformulac8h19nmolar mass129.247 g·mol−13d model (jsmol)interactive image smiles cc(c)cccc(c)n inchi inchi=1s/c8h19n/c1-7(2)5-4-6-8(3)9/h7-8h,4-6,9h2,1-3h3key:qnivimyxggftak-uhfffaoysa-n (verify) dmha has also been found as an adulterant in sports supplements and is sold online as a designer drug. related designer drugs methylhexanamine 1,3-dimethylbutylamine (dmba)